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South Africa continues to be home to the world’s largest population 
of people living with HIV.1 In developed countries such as the USA, 
the introduction of highly active antiretroviral therapy (HAART) 
as the mainstay of HIV treatment has resulted in impressive 
reductions in the incidence of severe HIV-associated neurocognitive 
disorders (HAND) and impacted favourably on survival rates 
in patients with HIV infection.2 Neurocognitive impairments, 
however, do not present universally among all HIV-infected 
persons. Neuropsychological signs and symptoms of at least mild 
extent have been found in approximately 30% of persons with 
asymptomatic HIV infection and about 50% of individuals with 
AIDS.
3
 Furthermore, despite the apparent reduction in the incidence 
of HIV-associated dementia (HAD), the incidences of milder forms 
of HAND appear relatively stable and may even have increased in 
individuals who are not immunosuppressed.
4
 Therefore, despite the 
remarkable improvements in the USA, HAND will probably remain 
a public health concern of increasing severity in South Africa, given 
that the majority of adults and children in the region in need of 
antiretroviral therapy do not have access to it. 
This article reviews the current diagnostic nosology for HAND 
and the neuropsychological domains typically affected by the HIV 
disease. The review concludes with a discussion of the commonly 
used neuropsychological screening tools for the detection and 
diagnosis of HAND.
Diagnostic nosology for HAND
The diagnostic nosology for HAND was revised and amended in 
2007 using recommendations from the US National Institutes of 
Health working group.
5
 The revisions emphasised that documented 
neurocognitive disturbance was an essential feature in the diagnosis 
of HAND, and specified more precise criteria for three syndromes: (i) 
asymptomatic neurocognitive impairment (ANI); (ii) HIV-associated 
mild neurocognitive disorder (MND); and (iii) HAD. These syndromes 
are discussed in turn below. 
Asymptomatic neurocognitive impairment (ANI)
This previously unclassified phenomenon is estimated to represent 
the majority of HAND cases (over 50% of diagnosed cases) and 
21 - 30% of asymptomatic HIV-infected individuals.
6
 ANI refers 
to mild slowing in mental acuity and loss of concentration, 
quantified as less than 1 standard deviation (SD) below the mean 
of demographically adjusted normative scores in the presence of 
intact everyday functioning. The fall-off is so subtle that it is best 
assessed with the use of neuropsychological assessment tools. 
This exercise of early assessment and diagnosis acts as way to pre-
identify patients at further risk of later and more significant cognitive 
as well as functional decline. The rationale of early identification 
premises that as effective treatments for neurological complications 
are developed, intervention at this early stage of HAND might 
represent the best chance to achieve remission, or at least delay the 
rapid progression of this debilitating disease.
Mild neurocognitive disorder (MND)
A diagnosis of MND requires evidence of mild to moderate 
neurocognitive impairment that represents at least 1 SD below 
the mean of demographically adjusted normative scores. To satisfy 
the diagnostic criteria, such impairment should occur in at least 
2 cognitive domains in the presence of mild functional fall-off. 
The requirement of mild functional impairment is satisfied when 
at least 2 of the following criteria are met: (i) patient or informant 
report of decline in at least 2 instrumental activities of daily living 
(bathing, dressing or financial management); (ii) unemployment or 
a significant reduction in job responsibilities secondary to reduced 
cognitive abilities; (iii) decline in vocational functioning (e.g. 
increased errors, decreased productivity, or greater effort required to 
achieve prior levels of productivity); (iv) patient or informant report 
of increased problems in at least 2 cognitive ability areas in day-
to-day life (this criterion cannot be used if based only on the self-
report of an individual with current depression, since depression 
may bias self-report); and (v) scores of 1 SD below the mean on a 




HIV infection is associated with disturbances in brain function 
referred to as HIV-associated neurocognitive disorders 
(HAND). This literature review outlines the recently revised 
diagnostic criteria for the range of HAND from the earliest to 
the more advanced stages: (i) asymptomatic neurocognitive 
impairment; (ii) mild neurocognitive disorder; and (iii) HIV-
associated dementia. Relevant literature is also reviewed 
regarding the differential impact upon component cognitive 
domains known to be affected in HAND, which in turn should 
ideally be targeted during clinical and neuropsychological 
assessments: psychomotor and information processing 
speed, learning and memory, attention and working memory, 
speech and language, executive functioning and visuospatial 
functioning. A discussion outlining the neuropsychological 
tools used in the diagnostic screening of HAND is also 
included. The central mechanisms of HAND appear to 
revolve primarily around psychomotor slowing and cognitive 
control over mental operations, possibly reflecting the 
influence of disrupted fronto-striatal circuits on distributed 
neural networks critical to cognitive functions. The accurate 
assessment and diagnosis of HAND depends on meeting the 
need for statistically sound neuropsychological assessment 
techniques that may be used confidently in assessing South 
African populations, as well as the development of relevant 
norms for comparison of test performance data. 
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HIV-associated dementia (HAD)
HAD represents the most severe form of HAND and is characterised 
by at least moderate to severe cognitive impairment that represents 
less than 2 SD below demographically adjusted normative means 
in at least 2 cognitive domains, in addition to a marked decline 
in the ability to complete activities of daily living. The functional 
impact resulting from HAD is particularly impairing. Two of the 
following functional deficits are required to fulfil the diagnostic 
criteria: (i) unemployment due to cognitive impairment; (ii) patient 
or informant report of dependence in at least 2 activities of daily 
living related to cognitive problems; (iii) patient or informant report 
of declines in at least 4 cognitive ability areas in day-to-day life; and 
(iv) performance at least 2 SD below the mean on a performance-
based laboratory measure of everyday functioning (or 1 SD below 
the mean on 2 functional tests).
7
 
Despite a marked decrease in the incidence of HAD after the 
advent of HAART (15 - 50%), it continues to be a significant cause 
of morbidity in HIV-infected patients. The prevalence, on the other 
hand, has increased due to the increased survival of HIV-infected 
patients resulting from the widespread use of HAART.
4
The neurocognitive profile of HAND
The cognitive deficits resulting from HAND can be global; 
however, psychomotor skills, speed of information processing, 
executive functions, episodic memory, attention/working 
memory, language and sensory perception are most commonly 
affected by HIV infection. These cognitive domains, typically 
targeted in the assessment of HAND, are discussed below. 
Motor skills and information processing
Severe movement abnormalities and psychomotor deficits can 
sometimes be observed in patients with HAD, most notably in 
the form of bradykinesia (slowed movement), hypomimia, action/
postural tremor and hand agility, as well as bradyphrenia (slowed 
information processing).
7
 HIV-associated motor slowing is often 




 and manual dexterity.
9 
Most 
neuropsychological tests are multi-factorial; in other words, 
they will probably provide information regarding a patient’s 
performance on a number of different cognitive domains. Slowed 
information processing speed can therefore be observed on tasks 
with and without motor demands. HIV-associated cognitive and 
motor slowing deficits are often exacerbated when controlled 
processing demands are increased, such as under conditions 
of divided attention.
10
 Furthermore, impaired performance on 
traditional tests of information processing speed could arise from 
a variety of deficits, including attention, visuoperception, working 
memory, praxis and basic motor skills. 
Learning and memory
In addition to psychomotor slowing, episodic deficits in both 
verbal and visual memory are considered highly sensitive 
indicators of HAND. These episodic memory difficulties among 
HIV-positive individuals appear highly prevalent, with most 
estimates ranging from 40% to 60%.
11
 Generally these impairments 
tend to be in the mild to moderate range, but they may worsen 
as the disease progresses, particularly with the onset of HAD.
12
 A 
significant proportion of HIV-infected patients display evidence 
of impaired immediate and delayed recall of information in the 
presence of relatively better ability to recognise the information 
when presented to them.
13
 Conversely, a smaller percentage of 




HIV infection is also associated with frequent prospective memory 
complaints, especially in aspects of daily functioning.
14
 Prospective 
memory entails one’s ability to successfully execute a future 
intention and involves the formation, maintenance, retrieval and 
execution of a future intention.
7
 It is essential for independent 
living and plays a critical role in daily duties such as employment, 
household responsibilities (e.g. financial management), social 
functioning and health care (e.g. medical compliance).
7
 On 
performance-based tests of prospective memory, including 
both time- and event-based tasks, HIV-positive individuals 




With regard to semantic memory, HAD seems associated with 
mild deficits in memory for famous faces and public events.
16
 The 
impact of HIV infection upon other aspects of declarative memory 
(e.g. semantic, autobiographical, emotional) as well as non-
declarative (i.e. implicit) memory appear quite poorly understood 
given a lack of empirical inquiry. 
Attention and working memory
As is the case with other neurocognitive domains, the severity of 
the attention/working memory impairment among individuals 
with HAND appears to be determined by the severity of the HIV 
disease and the complexity of the task (or the attentional load) 
presented during the assessment.
7
 During the early stages of the 
disease, basic attention and concentration skills appear relatively 
unscathed; however, during the later stages mild to moderate 
deficits tend to appear in persons with HAND.
17
 It appears that 
HIV is associated with mild deficits in basic attentional processes, 
which are amplified when processing demands are increased.
7
 
Additionally, a number of studies examining working memory (the 
ability to create a memory representation for temporary processing 
and storage) abilities of HIV-infected persons reveal the occurrence 
of difficulties with both visual and verbal working memory 
tasks.
18-20
 Furthermore, a number of studies have showed that 
attention/working memory deficits are among the strongest 
predictors of cognitive complaints among HIV-positive persons, 
predictive of medication adherence and significantly associated 
with driving ability (particularly the number of driving accidents in 
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Executive functioning
When compared with other cognitive domains, fewer studies 
have examined the underlying cognitive processes of executive 
dysfunction in HIV. This is surprising given the prevalence of 
executive deficits and their association with important functional 
outcomes. It is widely accepted that HIV is associated with executive 
dysfunction across neurocognitive impairment profiles, especially 
in the later stages of the disease.
21
 Executive dysfunction is strongly 
associated with impairments in everyday functioning, abstraction 
and novel problem-solving difficulties, deficits in social planning, 
and impairment in semantic event sequencing.
Visuoperception
It has generally been believed that spatial cognition remains 
largely unaffected by HIV infection. Some investigations employing 
standard clinical tests of visuospatial functioning were unable to 
detect significant impairment and as such supported this early 
hypothesis. However, recently the conclusions drawn from this 
early data have been questioned.
7
 More recent works now support 
the likelihood that subtle deficits exist in spatial cognition in HIV 
infection; however, the underlying aetiology remains unclear. 
Neuro-imaging research suggests that cortical thinning of parietal 
and frontal lobes is associated with cognitive impairment,
22
 but 
thorough investigations of spatial cognition in HIV are still needed 
to clarify the exact nature and origin of this impairment.
Speech and language
There appear to be very few large-scale investigations examining 
the basic aspects of speech and language in HIV infection in adults, 
as only a few case studies are available in the literature. Despite a 
lack of conclusive empirical evidence, the limited data available 
indicate that basic receptive (e.g. auditory comprehension) and 
expressive (e.g. repetition) language functions are generally within 
normal limits in HIV infection, although mild difficulties in the more 
complex aspects of expressive language may be observed.
23
 If 
present, general expressive language deficits tend to be mild in the 




Mild impairment in the pragmatic aspects of communication may 
also be evident, including turn-taking during conversations (e.g. 
inappropriate interruptions), poor lexical selection, and reduced 
fluency.
25
 Verbal fluency impairment is the most frequently identified 
language deficit in HIV and is estimated to occur in approximately 
40% of the population, albeit at generally mild presentations that 




Neuropsychological screening tools for HAND
Neuropsychological assessments are important tools for the 
purposes of diagnosing and categorising the effects of HIV on the 
central nervous system. Such methods are particularly useful in 
resource-limited settings such as South Africa where sophisticated 
neuro-imaging technology is often unavailable. When assessment 
tools are psychometrically sound (i.e. reliable and valid), and 
appropriate normative data are available for the population 
assessed, they can be quite sensitive to the nuances of even milder 
forms of cognitive impairment. The following neuro-psychometric 
tools have been used in the assessment of HIV-related cognitive 
disturbance:
 
The Mini-Mental State Examination (MMSE) was developed 
for the purpose of distinguishing Alzheimer’s dementia from 
other dementing disorders and as such consists of items that 
specifically intend to tap ‘cortical’ functions. The MMSE is not ideal 
for the assessment of HAND as sub-cortical processes are primarily 
affected; milder forms of HAND cannot be reliably detected, and 
age, education and cultural background appear to impact on its 
psychometric validity.
27
The HIV Dementia Scale comprises four items, an anti-saccadic 
eye movement error task, timed alphabet, verbal memory and 
copying a cube.
28
 It is more sensitive to subcortical functions and 
has been validated in South Africa,
29
 but can be difficult for non-
neurologists to administer without the necessary training.
27
The International HIV Dementia Scale (IHDS) consists of 
three subtests: timed alternating hand sequence, timed finger 
tapping, and recall of four items after 2 minutes. The IHDS has been 
recommended as an appropriate screening tool for neurocognitive 
disorder in general primary care settings as it is brief (can be 
completed in 2 - 3 minutes), the patient does not need knowledge 
of English, it can be performed by non-neurologists, and it does not 
require any special equipment other than a stop-watch.
27
 Despite 
these advantages and the fact that it was developed specifically for 
resource-limited settings, validation studies are needed to confirm 
its appropriateness for the local South African population. 
The Montreal Cognitive Assessment (MoCA) is a one-page 
30-point test administered in 10 minutes and particularly adept at 
accessing milder forms of cognitive impairment, more so than the 
MMSE. Details on the specific MoCA items are as follows. The short-
term memory recall task involves two learning trials of five nouns 
and delayed recall after approximately 5 minutes. Visuospatial 
abilities are assessed using a clock-drawing task and a three-
dimensional cube copy. Multiple aspects of executive functions 
are assessed using an alternation task adapted from trail making 
test B, a phonemic fluency task, and a two-item verbal abstraction 
task. Attention, concentration and working memory are evaluated 
using a sustained attention task (target detection using tapping), a 
serial subtraction task, and digits forward and backward. Language 
is assessed using a three-item confrontation naming task with 
low-familiarity animals (lion, camel, rhinoceros), repetition of two 
syntactically complex sentences, and the aforementioned fluency 
task. Finally, orientation to time and place is evaluated.
30
 Work to 
develop local normative data for this test is currently underway.
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More elaborate neuropsychological test batteries may be 
used for more complex cases or when time constraints are not 
an issue; however, in the absence of local population norms their 
appropriateness and utility are questionable. Singh
27
 and colleagues 
have collected population norms for the following bedside tests: 
digit span forward, digit span backwards, trail making test A and trail 
making test B. The neuropsychology battery utilised at Lentegeur 




The development of effective treatments for HIV have improved 
worldwide survival rates but at the same time have raised 
prevalence rates as well as increased the cognitive and functional 
impacts of the disease. The latter now represent a significant public 
health issue in South Africa. Concerted research efforts have shed 
some light on the cognitive profile of HAND, the central mechanisms 
of which appear to revolve primarily around psychomotor slowing 
and cognitive control over mental operations.
7
 Further clarification 
of these cognitive mechanisms is needed, especially those 
underlying executive dysfunction and planning deficits. These 
appear to play a central role in a number of aspects of everyday 
functioning. Future research efforts should focus on the efficacy of 
cognitive and behavioural remediation strategies of HAND as well 
as standardisation of neuropsychological assessments that assist in 
measuring problematic cognitive symptoms.
References
1. World Health Organization. Joint United Nations Programme on HIV/AIDS. Sub-Saharan 
Africa: Latest Epidemiological Trends. WHO, 2009.
2. Joska JA, Gouse H, Paul RH, Stein DJ, Flisher AJ. Does highly active antiretroviral therapy 
improve neurocognitive function? A systematic review. J Neurovirol 2010;16:101-114. 
3. Heaton RK, Grant I, Butters N, et al. The HNRC 500 – neuropsychology of HIV infection at 
different disease stages. J Int Neuropsychol Soc 1995;1:231-251.
4. Nath A, Schiess N, Venkatesan A, Rumbaugh J, Sacktor N, McArthur J. Evolution of HIV 
dementia with HIV infection. International Review of Psychiatry 2008;20:25-31.
5. Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV associated 
neurocognitive disorders. Neurology 2007;69:1789-1799.
6. Robertson KR, Smurzynski M, Parsons TD, et al. The prevalence and incidence of 
neurocognitive impairment in the HAART era. AIDS 2007;21:1915-1921.
7. Woods SP, Moore DJ, Weber E, Grant I. Cognitive neuropsychology of HIV-associated 
neurocognitive disorders. Neuropsychol Rev 2009;19:152-168. 
8. Robertson KR, Parsons TD, Sidtis JJ, et al. Timed gait test: normative data for the assessment 
of the AIDS dementia complex. J Clin Exp Neuropsychol 2006;28:1053-1064.
9. Martin EM, Pitrak DL, Novak RM, Edelstein HE, Chirurgi VA. Reaction times are faster 
in HIV-seropositive patients on antiretroviral therapy: A preliminary report. J Clin Exp 
Neuropsychol 1999;21:730-735.
10. Rippeth JD, Heaton RK, Carey CL, et al. Methamphetamine dependence increases risk of 
neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc 2004;10:1-
14.
11. Scott JC, Woods SP, Patterson KA, et al. Recency effects in HIV-associated dementia are 
characterized by deficient encoding. Neuropsychologia 2006;44:1336-1343.
12. Woods SP, Scott JC, Dawson MS, et al. Construct validity of Hopkins verbal learning 
test-revised component process measures in an HIV-1 sample. Arch Clin Neuropsychol 
2005c;20:1061-1071.
13. Woods SP, Carey CL, Moran LM, Dawson MS, Letendre SL, Grant I. Frequency and predictors 
of self-reported prospective memory complaints in individuals infected with HIV. Arch Clin 
Neuropsychol 2007;22:187-195.
14. Martin EM, Nixon H, Pitrak DL, et al. Characteristics of prospective memory deficits in 
HIV-seropositive substance-dependent individuals: preliminary observations. J Clin Exp 
Neuropsychol 2007;29:496-504.
15. Sadek JR, Johnson SA, White DA, et al. Retrograde amnesia in dementia: comparison of 
HIV-associated dementia, Alzheimer’s disease, and Huntington’s disease. Neuropsychology 
2004;18:692-699. 
16. Brew BJ. Evidence for a change in AIDS dementia complex in the era of highly active 
antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS 
2004;18(1):S75-S78.
17. Chang L, Tomasi D, Yakupov R, et al. Adaptation of the attention network in human 
immunodeficiency virus brain injury. Ann Neurol 2004;56:259-272.
18. Bartok JA, Martin EM, Pitrak DL, et al. Working memory deficits in HIV-seropositive drug 
users. J Int Neuropsychol Soc 1997;3:451-456.
19. Farinpour R, Martin EM, Seidenberg M, et al. Verbal working memory in HIV-seropositive 
drug users. J Int Neuropsychol Soc 2000;6:548-555.
20. Reger M, Welsh R, Razani J, Martin DJ, Boone KB. A meta-analysis of the neuropsychological 
sequelae of HIV infection. J Int Neuropsychol Soc 2002;8:410-424.
21. Poutiainen E, Iivanainen M, Elovaara I, Valle SL, Lähdevirta J. Cognitive changes as early signs 
of HIV infection. Acta Neurol Scand 1988;78:49-52.
22. Thompson PM, Dutton RA, Hayashi KM, et al. Thinning of the cerebral cortex visualized in 
HIV/AIDS reflects CD4+ T lymphocyte decline. Proc Natl Acad Sci USA 2005;102(43):15647-
15652.
23. Wolters PL, Brouwers P, Civitello L, Moss HA. Receptive and expressive language function 
of children with symptomatic HIV infection and relationship with disease parameters: a 
longitudinal 24-month follow-up study. AIDS 1997;11:1135-1144.
24. Iudicello JE, Woods SP, Weber E, Moran LM, Carey CL, Grant I. Cognitive mechanisms of 
switching in HIV-associated category fluency deficits. J Clin Exp Neuropsychol 2008;30:797-
804.
25. McCabe P, Sheard C, Code C. Pragmatic skills in people with HIV/AIDS. Disabil Rehabil 
2007;29:1251-1260.
26. Troyer AK. Normative data for clustering and switching on verbal fluency tasks. J Clin Exp 
Neuropsychol 2000;22:370-378.
27. Singh D. Neurocognitive impairment in PLWHA: Clinical features and assessment. South 
African Journal of HIV Medicine 2009; October: 30-34. 
28. Power C, Selnes OA, Grim JA, McArthur JC. HIV Dementia Scale: a rapid screening test. J 
Acquir Immune Defic Syndr Hum Retrovirol 1995;8(3):273-278.
29. Ganasen KA, Fincham D, Smit J, Seedat S, Stein D. Utility of the HIV Dementia Scale (HDS) 
in identifying HIV dementia in a South African sample. J Neurol Sci 2008;269(1-2):62-64.
30. Nasreddine ZS, Phillips NA, Be´dirian V, et al. The Montreal Cognitive Assessment, MoCA: 
A brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695-699. 
31. Vally Z. The assessment and management of dementia. South African Family Practice 
2010;52(5):392-395.
Erratum
In the article ‘The Brunel Mood Scale: A South African norm study’ by C van Wijk (Vol. 17 No. 2, pages 44-54), it should have been stated that 
the study was approved by the Surgeon-General’s Ethics Committee on Health Research. 
